Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 16963
Country/Region: Democratic Republic of the Congo
Year: 2016
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $4,168,904 Additional Pipeline Funding: $331,096

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $720,000
Care: Orphans and Vulnerable Children (HKID) $220,165
Care: TB/HIV (HVTB) $320,000
Care: Pediatric Care and Support (PDCS) $201,739
Laboratory Infrastructure (HLAB) $60,000
Health Systems Strengthening (OHSS) $50,000
Biomedical Prevention: Injection Safety (HMIN) $20,000
Testing: HIV Testing and Counseling (HVCT) $30,000
Sexual Prevention: Other Sexual Prevention (HVOP) $100,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $440,000
Treatment: Adult Treatment (HTXS) $1,707,000
Treatment: Pediatric Treatment (PDTX) $300,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 6,806
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 4,537
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 88,218
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 32,108
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 131,669
HTS_TST Service Delivery Point (Facility): Index testing 2017 796
HTS_TST Service Delivery Point (Facility): Inpatient 2017 19,098
HTS_TST Service Delivery Point (Facility): Malnutrition facilities 2017 7,162
HTS_TST Service Delivery Point (Facility): Other PITC 2017 7,162
HTS_TST Service Delivery Point (Facility): Outpatient 2017 44,561
HTS_TST Service Delivery Point (Facility): Pediatric 2017 10,209
HTS_TST Service Delivery Point (Facility): PMTCT 2017 39,658
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 2,227
HTS_TST Service Delivery Point (Facility): VCT 2017 796
HTS_TST Sum of Aggregated Age/Sex <15 2017 11,343
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 120,326
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 131,669
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 213
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 140
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 2,123
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,127
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 450
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 50
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 500
KP_PREV Total estimated number of key population in the catchment area 2017 625
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 563
KP_PREV_den By key population type: Men who have sex with men who are sex workers (Denominator: Total estimated number of key population in the catchment area 2017 62
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 46
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program 2017 54
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2017 65
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 869
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 580
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 1,449
PMTCT_ART Already on ART at beginning of current pregnancy 2017 164
PMTCT_ART New on ART 2017 364
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 39,848
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 229
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 282
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 2
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 2
PMTCT_EID Sum of Infant Age disaggregates 2017 511
PMTCT_STAT By: Known positives at entry 2017 188
PMTCT_STAT By: Number of new positives identified 2017 350
PMTCT_STAT Number of new ANC and L&D clients 2017 41,078
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 39,848
PMTCT_STAT Sum of Positives Status disaggregates 2017 538
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 10
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 90
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 12
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 120
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 256
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 232
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,485
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 84
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 1,238
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 162
TB_SCREENDX Screen Result: Screened Positive for TB 2017 1,650
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 3,231
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 4,301
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 331
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 414
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 8,277
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 85
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 826
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 107
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,104
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 2,122
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 2,227
TX_CURR Aggregated Age/Sex: <15 Female 2017 760
TX_CURR Aggregated Age/Sex: <15 Male 2017 507
TX_CURR Aggregated Age/Sex: 15+ Female 2017 6,726
TX_CURR Aggregated Age/Sex: 15+ Male 2017 2,353
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 10,346
TX_CURR Sum of Aggregated Age/Sex <15 2017 1,267
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 9,079
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 10,346
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 190
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 130
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 2,143
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 831
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 3,294
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 3,294
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 7,243
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 5,070
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 308
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 203
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 3,293
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 1,266
TX_PVLS Numerator: Indication: Routine 2017 5,020
TX_PVLS Numerator: Indication: Targeted 2017 50
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 435
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 290
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 4,706
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 1,812
TX_PVLS_den Denominator: Indication: Routine 2017 7,170
TX_PVLS_den Denominator: Indication: Targeted 2017 73
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 78
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 52
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 847
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 330
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,303
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,630
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 96
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 66
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,060
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 409